Astragalus Membranaceus Herb Helps Fight Leukemia
Author Information
Author(s): Yu Kunlin, Tang Yao, Wang Chunlin, Liu Wuling, Hu Maoting, Hu Anling, Kuang Yi, Zacksenhaus Eldad, Yu Xue-Zhong, Xiao Xiao, Ben-David Yaacov, Di Masi Alessandra
Primary Institution: State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University
Hypothesis
Can Astragalus membranaceus herb inhibit leukemia by targeting the FLI1 oncogene and enhancing anti-tumor immunity?
Conclusion
The study found that Astragalus membranaceus significantly inhibits leukemia progression in mice by targeting the FLI1 oncogene and enhancing immune responses.
Supporting Evidence
- Astragalus membranaceus injection significantly inhibited leukemia development in a mouse model.
- Chemical analysis identified compounds in Astragalus that bind to the FLI1 oncogene.
- Treatment with Astragalus led to increased apoptosis in leukemia cells.
- Immune checkpoint proteins IDO1 and TDO2 were targeted by Astragalus components.
Takeaway
Astragalus membranaceus is a plant that can help fight leukemia by stopping cancer cells from growing and boosting the body's defenses.
Methodology
The study used a mouse model of erythroleukemia induced by Friend virus and treated the mice with Astragalus membranaceus injection to assess its effects on leukemia progression.
Potential Biases
Potential bias may arise from the use of a single animal model and the lack of diverse demographic representation.
Limitations
The study does not explore the long-term effects of Astragalus treatment or its efficacy in human subjects.
Participant Demographics
Mice (BALB/c strain) were used in the study.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website